Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ravi Salgia

Showing results (1-10 of 528) with videos related to

Pageof 53
Sort By:
Journal of Carcinogenesis|November 15, 2008
Stamp out lung cancerRavi Salgia
Cancer Medicine|April 9, 2014
Fibroblast growth factor signaling and inhibition in non-small cell lung cancer and their role in squamous cell tumorsRavi Salgia
Molecular Cancer Therapeutics|April 5, 2017
MET in Lung Cancer: Biomarker Selection Based on Scientific RationaleRavi Salgia
Cancer|August 23, 2011
Prognostic significance of angiogenesis and angiogenic growth factors in nonsmall cell lung cancerRavi Salgia
Future Oncology (London, England)|February 13, 2015
Diagnostic challenges in non-small-cell lung cancer: an integrated medicine approachRavi Salgia
Expert Review of Molecular Diagnostics|May 4, 2016
Mutation testing for directing upfront targeted therapy and post-progression combination therapy strategies in lung adenocarcinomaRavi Salgia
Seminars in Oncology|April 28, 2009
Role of c-Met in cancer: emphasis on lung cancerRavi Salgia
Clinical Advances in Hematology & Oncology : H&O|January 21, 2022
The next targets for small cell lung cancerRavi Salgia
Clinical Advances in Hematology & Oncology : H&O|December 5, 2006
c-Met inhibitionRavi Salgia
Clinical Advances in Hematology & Oncology : H&O|September 10, 2015
MET as a drug targetRavi Salgia
Pageof 53

Showing results (1-10 of 528) with videos related to

Sort By:
Pageof 53
Journal of Carcinogenesis|November 15, 2008
Stamp out lung cancerRavi Salgia
Cancer Medicine|April 9, 2014
Fibroblast growth factor signaling and inhibition in non-small cell lung cancer and their role in squamous cell tumorsRavi Salgia
Molecular Cancer Therapeutics|April 5, 2017
MET in Lung Cancer: Biomarker Selection Based on Scientific RationaleRavi Salgia
Cancer|August 23, 2011
Prognostic significance of angiogenesis and angiogenic growth factors in nonsmall cell lung cancerRavi Salgia
Future Oncology (London, England)|February 13, 2015
Diagnostic challenges in non-small-cell lung cancer: an integrated medicine approachRavi Salgia
Expert Review of Molecular Diagnostics|May 4, 2016
Mutation testing for directing upfront targeted therapy and post-progression combination therapy strategies in lung adenocarcinomaRavi Salgia
Seminars in Oncology|April 28, 2009
Role of c-Met in cancer: emphasis on lung cancerRavi Salgia
Clinical Advances in Hematology & Oncology : H&O|January 21, 2022
The next targets for small cell lung cancerRavi Salgia
Clinical Advances in Hematology & Oncology : H&O|December 5, 2006
c-Met inhibitionRavi Salgia
Clinical Advances in Hematology & Oncology : H&O|September 10, 2015
MET as a drug targetRavi Salgia
Pageof 53